The activity of carbenicillin, ticarcillin, piperacillin, cefotaxime, moxalactam, and Nformimidoyl thienamycin was evaluated against 262 clinical isolates of Pseudoanams aeruginosa. There were 242 (92%) of the isolates that were susceptible to carbenicillin or ticarcillin by an agar dilution method.
derivative with a cephalosporin nucleus that has activity against P. aeruginosa'1. Moxalactam (LY 127935) has a substituted cephalosporin nucleus and is active against many Gram-negative enteric organisms, including strains with resistance mediated by beta-lactamases '-12) . N-Formimidoyl thienamycin (f-thienamycin, MK 0787) is a stable form of a novel beta-lactam antibiotic which has a fused ring nucleus and side chains that differ structurally from those of penicillin and cephalosporin compounds"-")
This study was designed to compare the relative activity of these beta-lactam antibiotics against a large number of recent clinical isolates of P. aeruginosa. The prevalence of carbenicillin resistance among clinical isolates of P. aernginosa and the frequency of cross-resistance with the newer beta-lactam agents were determined. The effects of inducible or constitutive beta-lactamases in P. aeruginosa upon the activity of these agents were assessed. Furthermore, the influence of gentamicin resistance upon susceptibility to the beta-lactam drugs was evaluated.
Materials and Methods

Organisms
A total of 262 isolates of P. aeruginosa were studied. These isolates comprised all of the P. aernginosa recovered from patients hospitalized at the Jackson Memorial Hospital during a three month interval. Consecutive isolates from the same patient were not included except for those recovered from THE JOURNAL OF ANTIBIOTICS different culture sites. The isolates were identified in the clinical microbiology laboratory using standard microbiologic procedures and biochemical methods").
Antibiotics
The antibiotics obtained in either standard reference powders or solutions for use in this study included carbenicillin and ticarcillin (Beecham Laboratories, Bristol, Tennessee) , moxalactam and tobramycin (Lilly Laboratories, Indianapolis, Indiana), piperacillin (Lederle Laboratories, Pearl River, New York), cefotaxime (Hoechst-Roussel, New Jersey), f-thienamycin (Merck, Sharp & Dohme , West Point, Pennsylvania), gentamicin (Schering Corp., Bloomfield, New Jersey), and amikacin (Bristol Laboratories, Syracuse, New York).
Susceptibility Studies
Minimal inhibitory concentrations (MICs) of these antibiotics were determined by the agar plate dilution method"). Serial two-fold dilutions of the antibiotics were added to MUELLER-HINTON agar to give final concentrations that ranged from 400 pg/ml to 0.01 pg/ml. The inoculum was prepared from a 4"5-hour broth culture of the organism, which was adjusted in turbidity to 107 CFU/ml and approximately 0.001 ml of the adjusted inoculum was applied to the plates by a STEER'S replicator18'. P. aeruginosa ATCC 27853 served as a control organism for the MIC determinations. The MIC was defined as the lowest concentration of antibiotic allowing either no visible growth or only one colony of growth after 18 hours of incubation at 37°C. An isolate was considered susceptible to carbenicillin/ticarcillin when its growth was inhibited at concentrations equal to or less than either 100 i'g/ ml of carbenicillin or 50 pg/ml of ticarcillin.
Beta-lactamase Studies Selected isolates were tested for the presence of inducible beta-lactamase activity by a disk approximation method similar to that described by SANDERS, et al.11). Commercially prepared cefoxitin disks (30 pcg) were placed on 15 x 100 mm plates containing approximately 15 ml of MUELLER-HINTON agar inoculated with a diluted suspension of organisms. Disks that contained 100 pg of carbenicillin, 50 jig of ticarcillin, 100 jig of piperacillin, 30 ieg of cefotaxime, 30 ,pg of moxalactam or 10 pg of f-thienamycin were placed 12 to 13 mm from the cefoxitin disk. Four antibiotics including carbenicillin and piperacil-]in were tested on each plate. These plates were incubated overnight at 37°C and measurements made of the radius of the zone of inhibition and the extent that it was reduced toward the cefoxitin disk.
A chromogenic cephalosporin method was used for the detection of beta-lactamase activity20). Nitrocefin (Compound 87/312) was obtained from Glaxo Research Ltd., England. One-tenth ml of the cephalosporin substrate was added to each test well of a microdilution plate. A suspension of cells, taken from the periphery of the MUELLER-HINTON test plate and from around the cefoxitin disks in the center, was added to separate wells. Similarly, a 0.1 ml aliquot of overnight broth cell suspension was also tested for activity. The development of the red color within 60 minutes indicated the presence of beta-lactamase activity. Constitutive beta-lactamase activity was demonstrated if the nitrocefin test was positive on the overnight broth suspension and with organisms taken from the periphery of the MUELLER-HINTON plate. An isolate was considered to have inducible beta-lactamase activity when the nitrocefin test was positive only in organisms obtained adjacent to the cefoxitin disk.
Results
Concentrations of 100 jig/ml of carbenicillin or 50 /.cg/m] of ticarcillin inhibited 242 (92 %) of 262 isolates of P. aeruginosa. This group included 11 isolates that had MICs in the susceptible range for one of these antibiotics but not the other. This population of susceptible isolates was used to obtain a set of data for each of the beta-lactam antibiotics. Each data set appeared to have a logarithmic normal distribution; the variability within these data sets was approximately similar as indicated by SDs which ranged from 0.8 to 1.2 in magnitude. Although these data sets had approximately equal variability, the MICs of the beta-lactam antibiotics against this population of susceptible P. aeruginosa isolates differed considerably ( Twenty-four isolates of P. aeruginosa that were susceptible to carbenicillin were randomly selected and tested for the presence of cefoxitin-induced inactivation of the beta-lactam antibiotics by a disk approximation assay. No isolate showed constitutive beta-lactamase activity; however, all had inducible
beta-] actamase activity in organisms grown around the cefoxitin disk. The mean radius of the zone of inhibition produced by each of the beta-lactarn antibiotics and the mean decrease that occurred toward the cefoxitin disk are presented in Table 2 . F-thienamycin was the only test antibiotic whose zone of inhibition was not diminished adjacent to the cefoxitin disk. All of the other agents showed a mean radial reduction toward the cefoxitin disk, although carbenicillin was affected to a lesser extent than ticarcillin, moxalactam or piperacillin. Cefotaxime was found to have the greatest reduction in mean radius and averaged 6.4 min. The cefoxitin-induced radial reduction did not correlate with either the MIC or the size of the uninduced zone of inhibition for any of the beta-lactam antibiotics (correlation coefficients <0.2).
The MIC for 90% (MIC80) of the susceptible isolates were used to evaluate the activity of the newer beta-lactam antibiotics against twenty (8%) of the P. aeruginosa isolates that were resistant to both carbenicillin and ticarcillin (Table 3 ). The proportions of carbenicillin resistant isolates that were susceptible to 12.5 irg/ml of piperacillin, 50 ftg/ml of cefotaxime and 100,ug/ml of moxalactam were 20%, 20%, and 5%, respectively. In contrast, 18 (90%) of 20 carbenicillin resistant P. aeruginosa 25 (21) 25 (22) 50 ( were inhibited by f-thienamycin at a concentration of 3.13 ug/ml.
A constitutive beta-lactamase was demonstrated in 4 (20 %) of the 20 carbenicillin resistant isolates.
Three of these with constitutive beta-lactamase activity were isolates not inhibited by 100 pg/ml of piperacillin. They were also resistant to carbenicillin, ticarcillin, cefotaxime and moxalactam. These isolates produced small or no zones of inhibition to these antibiotics in the disk assay. The other isolate that caused a positive nitrocefin reaction in broth culture was also resistant to these agents, but it seemed to have an inducible component by the disk approximation method. This isolate gave relatively large zones of inhibition; however, the inhibitory zones around most of the antibiotic disks were markedly reduced adjacent to the cefoxitin disk (Fig. 1) . The cefoxitin-induced radial reductions observed with this isolate were 35 % for carbenicillin, 48 % for ticarcillin, 48 % for piperacillin, 46 % for moxalactam and 78 % for cefotaxime. F-thienamycin was not affected by the inducible component of this isolate. The remaining 16 isolates gave a positive nitrocefin reaction with organisms taken from around the cefoxitin disk, but not from the periphery of the plate or from broth culture. The majority of these isolates had no zones or small zones of inhibition around all of the antibiotic disks except the f-thienamycin disk. The magnitude of the cefoxitin-induced radial reduction for the isolates giving appreciable zones of inhibition was equal to or less than that noted with susceptible isolates. Cefotaxime (50) Moxalactam (100) MIC (µg/ml) 3 Fifty-one (19%) of the 262 P. aeruginosa isolates were resistant to gentamicin at concentrations of 12.5 ftg/ml or more. Seven (13.7%) of the gentamicin resistant isolates were not inhibited by 100 pg/ ml of carbenicillin, however, this percentage was not significantly different from the percentage of gentamicin susceptible isolates that failed to be inhibited by this concentration of carbenicillin. The percentages of gentamicin resistant isolates that were also not inhibited by 6.25 icg/ml of tobramycin and 12.5 itg/ml of amikacin were 15.7% and 9.8%, respectively. Only two (22%) of the nine isolates that were resistant to more than one of these aminoglycoside antibiotics were resistant to carbenicillin.
Discussion
Most isolates of P. aeruginosa are susceptible to the activity of the beta-lactam antibiotics used in this study; however, differences between the activity of these agents are apparent. Differentiating a population of susceptible isolates from those that have resistance to antimicrobial activity alleviates the problem of selection, a factor limiting the interpretation of other studies. Studies which compare antibiotics on the basis of their median MIC do, however, provide an indication of relative activity of antimicrobials against a population of susceptible P. aeruginosa since the majority of isolates are likely to be in this population.
F-thienamycin and piperacillin are the only beta-lactam drugs that are more active than ticarcillin against a population of susceptible P. aeruginosa. That cefotaxime is not more active than ticarcillin confirms the finding of NEU, et al.'). The present study, however, indicates that moxalactam is less active than ticarcillin or cefotaxime. This finding differs from those of most other studies which have indicated that moxalactam is as active as these antibiotics'-10,12> The activity of moxalactam against Enterobacteriaceae tested in our laboratory is similar to other published reports; the geometric mean MICs of moxalactam are 0.17 tug/ml for Escherichia coli, 0.20,ug/ml for Klebsiella pneumoniae, 0.32 iig/ ml for Serratia marcescens, 0.16 icg/ml for Proteus mirabilis (unpublished data). The reasons for the divergent conclusions regarding the activity of moxalactam against P. aeruginosa are not known; however, a recent study has been more consistent with our findings").
SYKES, et al. reported that all susceptible P. aeruginosa have an inducible beta-lactamase which is primarily a cephalosporinase, similar to that initially described by SABATH, et al. 22, 23) . Our observations in the disk approximation assay indicate that cefotaxime is particularly susceptible to inactivation by this beta-lactamase, while f-thienamycin is evidently unaffected. Our data suggest that the inducible betalactamase also affects penicillin derivatives, although carbenicillin is affected to a lesser extent than either ticarcillin or piperacillin. Moxalactam appears to be susceptible to inactivation by the inducible beta-lactamase, although the reduction in moxalactam activity is less than that of cefotaxime. The expression of the inducible beta-lactamase observed in the disk approximation assay is not correlated with either the MIC or the size of inhibitory zone. This finding suggests that the presence of an inducible beta-lactamase is not a factor in these tests of in vitro susceptibility. Nevertheless, it could account for the rapid emergence of resistance in vivo.
Several plasmid-mediated beta-lactamases have been identified in carbenicillin resistant P. aeruginosa and the substrate profiles of these enzymes are known to differ","'.
Constitutive beta-lactamases found in P. acruginosa are known to inactivate piperacillin to a variable extent, but not cefotaxime or moxalactam25). Cefotaxime is susceptible to hydrolysis by the beta-lactamases of other Gram-negative organisms28n. Several investigations, however, indicate that moxalactam resists hydrolysis by these Gram-negative beta-lactamases5 7,27. The present study shows that cross-resistance between betalactam drugs and moxalactam does exist in P. aeruginosa. The finding that constitutive beta-lactamase activity accounts for antimicrobial resistance in only 20% of the carbenicillin resistant isolates is similar to that reported by KING, et al28). Therefore, it appears that permeability of the antibiotics through the cell wall is a more common mechanism for resistance to beta-lactam antibiotics than is enzymatic inactivation").
Our results confirm the findings of other investigations that f-thienamycin does not share cross-resistance with other beta-lactam drugs30'32>. Strains of P. aeruginosa that were resistant to the other beta-lactam drugs were as susceptible to f-thienamycin as were the carbenicillin/ticarcillin susceptible isolates.
Although the proportion of resistant isolates varies from institution to institution, resistance to gentamicin among P. aeruginosa has become a more frequent occurrence than resistance to carbenicillin. This may be related to the relative use of these drugs 13) ; however, resistance to carbenicillin or the other beta-lactam antibiotics occurs independently of resistance to the aminoglycosides. Several studies may have failed to demonstrate cross-resistance with the newer beta-lactam drugs because aminoglycoside resistant organisms were studied'`'' Several factors will affect the extent that these antibiotics will be useful in the treatment of Pseudomonas infections. Some of the newer antibiotics may be advantageous since they are active against P. aeruginosa at considerably lower concentrations than the presently available agents. Resistance to the inducible beta-lactamase of P. aeruginosa is another consideration. The prevalence of organisms that are resistant to the available antibiotics and the lack of cross-resistance with these agents are likely to be equally important.
